标普和纳斯达克内在价值 联系我们

NanoString Technologies, Inc. NSTG NASDAQ

NASDAQ Global Market • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
39/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$21.50
+20317.9%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

NanoString Technologies, Inc. (NSTG) .

本页证实的标准:

  • VALUE (100/100, 通过) — 分析师目标价暗示上行空间 (+20317.9%).
  • 分析师共识目标价 $21.50 (+20317.9% 上行空间) — 华尔街分析师认为存在显著上行潜力。

SharesGrow 综合评分: 39/100 其中 2/7 项标准通过。

SharesGrow 7-Criteria Score
39/100
SG Score
View full scorecard →
价值
100/100
Price-to-Earnings & upside
Proven by this page
未來
64/100
Analyst consensus
→ Forecast
过去
0/100
→ Income
健康
33/100
Debt-to-Equity & liquidity
→ Health
护城河
36/100
→ Income
成长
30/100
→ Income
收入
10/100
→ Income

估值概览 — NSTG

估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.04
EV/EBITDA0.0
每股数据
EPS (TTM)$-3.44
每股账面价值$0.00
每股营收$2.74
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
分析师目标价$21.50 (+20317.9%)

EPS:实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2013 $-3.83 $31.4M $-29.28M -93.2%
2014 $-2.80 $47.59M $-50.04M -105.1%
2015 $-2.40 $62.67M $-45.58M -72.7%
2016 $-2.34 $86.49M $-47.09M -54.4%
2017 $-1.84 $114.91M $-43.56M -37.9%
2018 $-2.78 $106.73M $-77.4M -72.5%
2019 $-1.18 $125.57M $-40.7M -32.4%
2020 $-2.82 $117.32M $-110.08M -93.8%
2021 $-2.54 $145.09M $-115.25M -79.4%
2022 $-3.44 $127.26M $-159.54M -125.4%
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言